Prokidney (PROK) Cash from Operations (2021 - 2026)
Prokidney (PROK) reported Cash from Operations of 41684000.0 for Q1 2026, down 40.86% year-over-year from 70486453.03 in Q1 2025, and down 28.21% quarter-over-quarter from 32513000.0 in Q4 2025.
Prokidney (PROK) Cash from Operations (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Cash from Operations data on file, last reported at 41684000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 41684000.0, down 40.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 132209000.0 (down 9.0% YoY), and the FY2025 annual result was 120117000.0, up 4.93% from the prior year.
- Cash from Operations declined to 41684000.0 in Q1 2026 per PROK's latest filing, from 32513000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 14916000.0 in Q2 2023 and troughed at 41684000.0 in Q1 2026.
- A 5-year average of 26782941.18 and a median of 25992000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations tumbled 11202073.91% in 2022, then soared 35.22% in 2023.
- A 5-year view of Cash from Operations shows it stood at 15761000.0 in 2022, then slumped by 61.06% to 25384000.0 in 2023, then climbed by 4.78% to 24171000.0 in 2024, then tumbled by 34.51% to 32513000.0 in 2025, then decreased by 28.21% to 41684000.0 in 2026.
- Business Quant data shows PROK's Cash from Operations at 41684000.0 in Q1 2026, 32513000.0 in Q4 2025, and 26596000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -41.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.68 Mn |
| Mar 31, 2026 | -41.68 Mn |
| Dec 31, 2025 | -32.51 Mn |
| Dec 31, 2025 | -32.51 Mn |
| Sep 30, 2025 | -26.60 Mn |
| Sep 30, 2025 | -26.60 Mn |
| Jun 30, 2025 | -31.42 Mn |
| Jun 30, 2025 | -31.42 Mn |
| Mar 31, 2025 | -29.59 Mn |
| Mar 31, 2025 | -29.59 Mn |
| Dec 31, 2024 | -24.17 Mn |
| Dec 31, 2024 | -24.17 Mn |
| Sep 30, 2024 | -29.24 Mn |
| Sep 30, 2024 | -29.24 Mn |
| Jun 30, 2024 | -38.29 Mn |
| Jun 30, 2024 | -38.29 Mn |
| Mar 31, 2024 | -34.65 Mn |
| Mar 31, 2024 | -34.65 Mn |
| Dec 31, 2023 | -25.38 Mn |
| Dec 31, 2023 | -25.38 Mn |